Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Clinical Applications While human trials are limited and 5-Amino-1MQ is not FDA-approved as a therapeutic agent, its mechanism and early research suggest potential benefits in: Weight management and body recomposition Adiposity reduction and fat loss Insulin sensitivity improvement Metabolic syndrome support NAD optimization and anti-aging protocols Cellular energy and endurance enhancement Adjunct to exercise or caloric restriction protocols It may be particularly relevant for individuals with stubborn fat loss resistance , age-related metabolic decline, or those using NAD-supportive therapies like NMN or NR
To minimise freezethaw, prepare aliquots according to your protocol
AOD 9604 Clinical Trial History: What the Research Actually Shows Six Phase I and Phase II clinical trials were conducted by Metabolic Pharmaceuticals Ltd., enrolling approximately 900 participants in total
Supplementing melatonin in aged rodents has been shown to improve mitochondrial respiration efficiency, reduce lipid peroxidation, and even extend lifespan in some studies
US$ 23.77
US$ 26.39
US$ 23.66
US$ 20.81
US$ 26.17
US$ 29.57
US$ 26.99
US$ 23.52